References
- BlumerJLClinical pharmacology of midazolam in infants and childrenClin Pharmacokinet199835237479673833
- PeetersMYPrinsSAKnibbeCAPharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgeryAnesthesiology200610561135114617122576
- de WildtSNde HoogMVinksAAvan der GiesenEvan den AnkerJNPopulation pharmacokinetics and metabolism of midazolam in pediatric intensive care patientsCrit Care Med20033171952195812847388
- DavisPJCookDRStillerRLDavin-RobinsonKAPharmacodynamics and pharmacokinetics of high-dose sufentanil in infants and children undergoing cardiac surgeryAnesth Analg19876632032082950809
- Woloszczuk-GebickaBGrabowskiTBoruckaBKaras-TrzeciakMPharmacokinetics of sufentanil administered with 0.2% ropivacaine as a continuous epidural infusion for postoperative pain relief in infantsPaediatr Anaesth201424996296724824135
- BradleyJSWasselRTLeeLNambiarSIntravenous ceftraxione and calcium in the neonate: assessing the risk for cardiopulmonary adverse eventsPediatrics20091234609613
- MonteSVPrescottWAJohnsonKKKuhmanLPaladinoJASafety of ceftriaxone sodium at extremes of ageExpert Opin Drug Saf20087551552318759704
- YaoYZhouRWangYFatal adverse effects of injected ceftriaxone sodium in ChinaPharmacoepidemiol Drug Saf201221111197120122761158
- Atanasković-MarkovićMVelickovićTCGavrović-JankulovićMVuckovićONestorovićBImmediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in childrenPediatr Allergy Immunol200516434134715943598
- BelliardCRSibilleGAnaphylactoid shock or precipitation of calcium-ceftriaxone in a premature newborn. A case reportArch Pediatr200714219920017166703
- RomanoACaubetJCAntibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosisJ Allergy Clin Immunol Pract20142131224565763
- MartinEFanconiSKälinPCeftriaxone-bilirubin-albumin interactions in the neonate an in vivo studyEur J Pediatr199315265305348335024
- McCrackenGHJrSiegelJDThrelkeldNThomasMCeftriaxone pharmacokinetics in newborn infantsAntimicrob Agents Chemother19832323413436301369
- European Medicines AgencyAnnex III. Summary of product characteristics, labelling and package leaflet Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Rocephin_30/WC500160113.pdfAccessed May 15, 2015
- GökçeSYildirimMErdoğanDA retrospective review of children with gallstones: single-center experience from Central AnatoliaTurk J Gastroenterol2014251465324918130
- RivkinAMHepatocellular enzyme elevations in a patient receiving ceftriaxoneAm J Health Syst Pharm200562192006201016174837
- AlehosseinMSotoudehKNasoohiSSalamatiPAkhtare-KhavariHCeftriaxone induced biliary pseudocholelithiasis in children. Report of 14 casesIran J Pediatr20081813137
- SoysalAErasovKAkpinarIBakirMBiliary precipitation during ceftriaxone therapy: frequency and risk factorsTurk J Pediatr200749440440718246742
- BinerBOnerNCeltikCCeftriaxone-associated biliary pseudolithiasis in childrenJ Clin Ultrasound200634521722216673364
- KutuyaNOzakiYOkazakiTSymptomatic child with ceftriaxone-associated biliary pseudocholithiasisJ Med Ultrason (2001)200835125128
- PacificiGMPharmacokinetics of cephalosporins in the neonate: a reviewClinics (Sao Paulo)20116671267127421876985
- HamiltonJLJohnSPEvaluation of fever in infants and young childrenAm Fam Physician201387425426023418797
- http://www.fda.gov Available from: http://www.fda.gov/downloads/Safety/MedWatch/safetyInformation/Safetyalertsforhumanmedical-products/ucm165639.pdfAccessed May 15, 2015
- World Health OrganizationCeftriaxone – safety in neonates Available from: http://www.who.int/selection_medicines/committees/subcommittee/2/Ceftriaxone.pdfAccessed May 15, 2015
- Van ReemptsPJVan OvermeireBMahieuLMVanckerKJClinical experience with ceftriaxone treatment in the neonateChemotherapy19954143163227555213
- BradleyJSBocchiniJAFDA eases restrictions on use of ceftriaxone in infantsAAP News2009302810.1542/aapnews.2009306-28
- SteadmanERaischDWBennettCLEvaluation of a potential interaction between ceftriaxone and calciumAntimicrob Agents Chemother20105441534154020086152
- GulianJMDalmassoCPontierFGonardVDisplacement effect of ceftriaxone on bilirubin bound to human serum albuminChemotherapy19863253994033757585
- Abu TeirMMGhitanJAbu-TahaMIDarwishSMAbu-HadidMMSpectroscopic approach of the interaction study of ceftriaxone and human serum albuminJ Biophys Struct Biol201461112
- SchaadUBTschäppelerHLentzeNJTransient formation of precipitations in the gallbladder associated with ceftriaxone therapyPediatr Infect Dis1986567087103540889
- SchaadUBWedgwood-KruckoJTschäppelerHReversible ceftriaxone-associated biliary pseudolithiasis in childrenLancet198828625141114132904533
- AlamMKBaslul KarimASMKabirMHHuqueSSSamsuzzamanMCeftriaxone associated biliary sludge in children – a study in Bangabandhu Sheikh Mujib Medical UniversityBangladesh J Child Health2013373142145
- BickfordCLSpencerAPBiliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literaturePharmacotherapy200525101389139516185184
- SchaadUBStoeckelKSingle-dose pharmacokinetics of ceftriaxone in infants and young childrenAntimicrob Agents Chemother19822122482536280597
- PrinceJSSenacMOJrCeftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a childPediatr Radiol200333964865112830336
- MilohTKotlus RosenbergHKochinIKerkarNInspissated bile syndrome in a neonate treated with ceftriaxoneJ Ultrasound Med20092854154419321684
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508
- AklKFMasriATHjazeenMMAcute urinary retention induced by ceftriaxoneSaudi J Kidney Dis Transpl20112261226122822089789
- FratzayasALiapiOPapadopoulouANicolaidouPStamoulakatouAIs ceftriaxone-induced biliary pseudocholithiasis influenced by UDP-glucuronosyltransferase 1A1 gene polymorphisms?Case Rep Med2011201173025022110515
- SteeleRWEyreLBBradsherRWWeinfeldREPatelIHSpicehandlerJPharmacokinetics of ceftriaxone in pediatric patients with meningitisAntimicrob Agents Chemother19832321911946301362
- Hammett-StablerCAJohnsTLaboratory guidelines for monitoring of antimicrobial drugsClin Chem1998445112911409590397
- BeggEJBarclayMLKirkpatrickCJMThe therapeutic monitoring of antimicrobial agentsBr J Clin Pharmacol1999471233010073735
- PapadopoulouFEfremidisSKarydaSIncidence of ceftriaxone-associated gallbladder pseudolithiasisActa Paediatr1999881352135510626521
- AlemayehuHDesaiAAThomasPSharpSWSt PeterSDCeftriaxone-induced pseudolithiasis in children treated for perforated appendicitisPediatr Surg Int20143033233224464035
- AndruszkiewiczPSobczykDUltrasound in critical careAnaesthesiol Intensive Ther20134517718124092516